1Masse M. Universal leukoreduction of cellular and plasma components: process control and performance of the leukoreduction process[J]. Transfus Clin Biol, 2001,8 (3) :297-302.
2Fukunaga K, Shimoyama T, Yamaji K, et al. In vitro comparison study of CD63 and CD62p expression after contacting leukocyte filters[J]. Artif Organ, 1999,23 (1): 108-112.
3Racz Z. Characteristics of lymphocytes and granulocytes removed from whole blood by buffy coat depletion. Comparison of an automated bottom-and-Top processing system and the manual technique[J]. Arch Med Res, 2000,31(1):53-57.
4Royer D, Pommier P,Polidori Y, et al. The platelet/leukocyte ratio in red blood cell concentrates is an essential indicator of leukocyte removal filter efficiency which limits their use[J]. Transfus Clin Biol, 2000,7 (1): 70-75.
5Hammer JH, Mynster T, Reimert CM, et al. Reduction of bioactive substances in stored donor blood:prestorage versus bedside leucofiltration[J]. Eur J Haematol, 1999,63(1) :29-34.
7Nomura S, Okamae F, Abe M, et al. Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes[J]. Clin Appl Thromb Hemost,2000,6(4):213-21.
9Asai T, Inaba S, Ohto H, et al. Guidelines for irradiation of blood and blood components to prevent post-transfusion graft-vs -host disease in Japan[J]. Transfus Med,2000,10(4) :315-320.
10Muller-Steinhardt M, Schlenke P, Wagner T, et al.Transfusion of platelet concentrates from pooled buffycoats:comparison of bedside vs. prestorage leukofiltration[J]. Transfus Med,2000,10(1) :59-65.
